Cite
Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease
MLA
Yılmaz, Yusuf, et al. Noninvasive Assessment of Liver Fibrosis with the Aspartate Transaminase to Platelet Ratio Index (APRI): Usefulness in Patients with Chronic Liver Disease. Feb. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......9458..504544c43777fcc6014ad3f58d8ee7d0&authtype=sso&custid=ns315887.
APA
Yılmaz, Y., Yönal, O., Kurt, R., Aktaş, B., & Özdoğan, O. (2011). Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease.
Chicago
Yılmaz, Yusuf, Oya Yönal, Ramazan Kurt, Bilge Aktaş, and Osman Özdoğan. 2011. “Noninvasive Assessment of Liver Fibrosis with the Aspartate Transaminase to Platelet Ratio Index (APRI): Usefulness in Patients with Chronic Liver Disease,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......9458..504544c43777fcc6014ad3f58d8ee7d0&authtype=sso&custid=ns315887.